Research has suggested that bacteriophages derived and manipulated from ExPEC reservoirs are capable of combating infections caused by E.coli ‘superbugs’.
Browsing: Disease Area > Bacterial
Oral delivery of vaccines is an attractive approach but is hampered by a number of challenges. Here, the authors discuss the need to include immunostimulatory adjuvants in oral vaccines to overcome oral tolerance and elicit effector immune responses locally within the intestine.
This study delves aims to evaluate the efficacy of durancin 61A as an inhibitor of resistant clinical pathogens and to shed light on its mode of action.
Read our report from the second state-of-the-art symposium on nontuberculosis mycobacteria (NTM) infections covering diagnosis, biology, epidemiology and more.
New research suggests that maternal vaccination may be the most effective strategy for preventing pertussis in infants throughout the first year of life.
How can we ensure products remain pathogen free? In this editorial, the authors discuss the most common causes of food-borne illnesses, methods by which contamination is traditionally detected and what current research has to offer, specifically in the field of nanoscience.
A team of UK-based researchers have been awarded a major grant to investigate the relationship between alterations in the gut microbiota and neurodegenerative disorders.
In this podcast Dr Elizabeth Whittaker, Dr James Seddon, Dr Pete Dodd and Professor Beate Kampmann discuss their work in pediatric tuberculosis focusing on the areas of immunology, modelling and drug resistance.
Take a look at our new infographic, developed for World Tuberculosis Day, which explores the facts about current TB burden, the issues around drug resistance, and research and development moving forwards.